National Taiwan University Hospital: Esophageal Neoplasms trials

The registry lists 20 Esophageal Neoplasms studies with National Taiwan University Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 8No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AI-Based Risk Prediction Model for Upper Digestive Tract CancerNot yet recruitingNCT07605312
• ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer PatientsRecruitingNCT07322627
• Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell CarcinomaRecruitingNCT07152678Phase 2
• To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for RecurrenceRecruitingNCT05376423Phase 2
• The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1)CompletedNCT06424210
• Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT05007613Phase 2
• The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT03800953Phase 2
• The Comparison of Single and Multi-incision MIE for Esophageal CancerStatus unknownNCT03646110Not applicable
• The Effects on Major Organ Complications on Esophagectomy of New Anesthetic ERAS Strategy: a Prospective InvestigationStatus unknownNCT03176680Not applicable
• Different Anesthetic Managements of Esophageal Resection and ReconstructionStatus unknownNCT02961140Not applicable
• Effects of a "Walk, Eat, & Breathe" Nursing Intervention For Patients With Esophageal CancerStatus unknownNCT02850172Not applicable
• MR/PET in the Evaluation of Patients With Esophageal CancerStatus unknownNCT02547610
• Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal CancerStatus unknownNCT02017002Not applicable
• PLA for HCC and Esophageal ca SerumStatus unknownNCT01957241
• Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer PatientCompletedNCT01952210Not applicable
• Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal CancerStatus unknownNCT01927978
• Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal CancerStatus unknownNCT01034332Phase 2
• Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal CancerStatus unknownNCT01034189Phase 2
• CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal CancerCompletedNCT00154804Phase 2
• Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal CancerCompletedNCT00154700Phase 2